17B-Hydroxyestr-4-En-3-One 17-(3-Phenylpropionate) 苯丙酸诺龙

CAS 62-90-8 MFCD00198407

化学结构图

62-90-8
SMILES: CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2OC(=O)CCC1CCCCC1

化学属性

Mol. FormulaC27H34O3
Mol. Weight406.61
Appearance 白色或乳白色结晶性粉末，有特殊臭。几乎不溶于水，溶于乙醇或脂肪油，熔点93-99℃。

别名和识别编码

Chemical Name17B-Hydroxyestr-4-En-3-One 17-(3-Phenylpropionate)
CAS Number62-90-8
Synonym Nandrolone phenylpropionate {un 17-b 4-ESTREN-17BETA-OL-3-ONE 17-PHENYLPROPIONATE (17β)-(1-oxo-3-phenylpropoxy)estr-4-en- 17-beta-Phenylpropionyloxy-4-estren-3-one 17β-hydroxyestr-4-en-3-on 17-beta-hydroxy-estra-4-en-3-one,17-phenylpropionate 17-beta-hydroxyestr-4-en-3-one hydrocinnamate (17?)-17-(1-Oxo-3-phenylpropoxy)-estr-4-en-3-one 17-beta-Hyd 苯丙酸诺酮 usp限制 19-NORTESTOSTERONE PHENYLPROPIONATE Fenobolin 苯丙酸去甲睾酮 {Chemicalb Superanabolon Estr-4-en-3-one, 17-(1-oxo-3-phenylpropoxy)-, (17-beta)- 19-Nortestosterone phenylpropionate nandrolone phenpropionate 19-去甲基睾丸素苯丙酸酯 {Chemicalboo 17-(1-oxo-3-phenylpropoxy)estr-4-en-3-one 17-beta-hydroxy-estr-4-ene-3-on3-phenylpropionate 17?-(3-Phenylpropionyloxy)-estr-4-en-3-one 19-Norandrostenolone phenylpropionate 19-Nor-17?-hydroxy-3-ketoandrost-4-ene 17-phenylpropionate 17b-hydroxyestr-4-en-3-one 3-phenylpropionate NANDROLONI PHENYLPROPIONAS 苯丙酸诺龙 NANDROLONE PHENYLPROPIONATE 17b-hydroxyestr-4-en-3-one 17-(3-phenylpropionate) Nandrolone phenpropionate Nortestosterone phenylpropionate Phenobolin Estr-4-ene-3-one, 17-beta-hydroxy-, 3-phenylpropionate 19-Nortestosterone phenylpropionate; 17b-hydroxyestr-4-en-3-on 4-ESTREN-17-BETA-OL-3-ONE PHENYLPROPIONATE 19-Nortestosterone, hydrocinnamate Nerobil 17b-hydroxyestr-4-en-3-one3-phenylpropionate NTPP Nerobiolil NANDROLONE PHENPROPIO Durabolin 4-ESTREN-17B-OL-3-ONE 17-PHENYLPROPIONATE {hazard_c
EC Number200-551-9
MDL NumberMFCD00198407
Chemical Name Translation苯丙酸诺龙
Wiswesser Line NotationL E5 B666 OV MUTJ E1 FOV2R
Beilstein Registry Number3170861
PubChem Substance ID229455
InChIInChI=1S/C27H34O3/c1-27-16-15-22-21-11-9-20(28)17-19(21)8-10-23(22)24(27)12-13-25(27)30-26(29)14-7-18-5-3-2-4-6-18/h2-6,17,21-25H,7-16H2,1H3/t21-,22+,23+,24-,25-,27-/m0/s1
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Pharmaceuticals
  • Intermediates & Fine Chemicals
  • Steroids
  • {uni_hamburg} no charge; carbocycle; aromatic; alicycle; large ring; fused rings; 5ring; 6ring; 9ring; 10ring; 13ring; 14ring; 17ring; ester; ketone; 1fragment

产品应用

  • Anabolic Steroid.

相关文献及参考

  • Thevis, M., et al.: J. Anal. Toxicol., 32, 232 (2008),
  • Pagonis, T., et al.: Clin. Toxicol., 46, 57 (2008),
  • Short: IV/8A Title: Enthalpies of Fusion and Transition of Organic Compounds Author: Zhang, Z.-Y.; Frenkel, M.; March, K.N.; Wilhoit, R.C. Editor: Marsh, K.N. Source: Landolt-Börnstein, New Series Volume: IV/8A Year: 1995 Keyword: organic compounds; enthaly of fusion; melting point; phase transition ISBN: 3-540-58854-X ISBN: 978-3-540-58854-2 Internet Resource: DOI:10.1007/b55145 RefComment: VIII, 588 pages.
  • Short: EINECS Title: EINECS (European Inventory of Existing Commercial Chemical Substances) Source: Official Journal of the European Communities Volume: C 146 A (15.06.1990) Page: 1 Year: 1990 Internet Resource: http://ecb.jrc.ec.europa.eu/esis/index.php?PGM=ein Publish_Date: 1990/06/15

安全信息

RTECSKG7995000 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : >1 gm/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NIIRDN Drugs in Japan (Ethical Drugs).  (Yakugyo Jiho Co., Ltd., Tokyo,
   Japan)  Volume(issue)/page/year: 6,541,1982

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 595 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   PCJOAU Pharmaceutical Chemistry Journal (English Translation).  Translation
   of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013)  No.1-
   1967-  Volume(issue)/page/year: 20,143,1986

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 60 mg/kg
SEX/DURATION            : female 7-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intramuscular
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 3750 ug/kg
SEX/DURATION            : female 9-14 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
   Reproductive - Specific Developmental Abnormalities - urogenital system
   Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
   gain)
REFERENCE :
   OYYAA2 Oyo Yakuri.  Pharmacometrics.  (Oyo Yakuri Kenkyukai, CPO Box 180,
   Sendai 980-91, Japan) V.1-    1967-  Volume(issue)/page/year: 7,723,1973

{hazard_com

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 14850 ug/kg
SEX/DURATION            : male 11 day(s) pre-mating
TOXIC EFFECTS :
   Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland,
   accessory glands
REFERENCE :
   ARZNAD Arznei

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intramuscular
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 15 mg/kg
SEX/DURATION            : female 7-12 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
   Reproductive - Specific Developmental Abnormalities - urogenital system
   Reproductive - Effects on Newborn - live birth index (measured after birth)
REFERENCE

其他信息

  • 用途一:用于发育不良、营养失调、消耗性疾患的治疗。
  • MOL 文件:62-90-8.mol

系列性分类

相关产品推荐